Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Subcutaneous Immunoglobulin (SCIG) injection bulk supplier for pharma manufacturers

Subcutaneous Immunoglobulin (SCIG) Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 20% solution (200 mg/mL), vials

Reference Brands: Hizentra, Cuvitru (US/EU)

Category: Plasma Products

Subcutaneous immunoglobulin (SCIG) is a concentrated antibody preparation that patients with primary immunodeficiency can infuse under the skin at home, weekly or every two weeks. It gives steadier antibody levels than monthly IVIG. Reference products include Hizentra and Cuvitru (20%). Each batch carries a plasma-product release certificate. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Subcutaneous Immunoglobulin (SCIG) Injection? List it or send an offer →

Product Description:

Subcutaneous Immunoglobulin (SCIG), marketed as Hizentra and Cuvitru, is approved in the US by the FDA and in the EU via EMA for primary immunodeficiency and autoimmune diseases. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves detailed assessment of clinical trials and manufacturing standards, while the EMA ensures compliance with regional quality and safety requirements. Ensuring compliance is crucial for the safe, effective, and timely approval of SCIG products worldwide, supporting better patient outcomes.

Subcutaneous Immunoglobulin (SCIG) Injection — third party manufacturing & bulk supply

Subcutaneous Immunoglobulin (SCIG) Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Subcutaneous Immunoglobulin (SCIG) Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Subcutaneous Immunoglobulin (SCIG) Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Subcutaneous Immunoglobulin (SCIG) Injec... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Subcutaneous Immunoglobulin (SCIG) is used to treat patients with primary immunodeficiency disorders and certain immune system deficiencies. It helps strengthen the immune system by providing antibodies that protect the body from infections.

Subcutaneous Immunoglobulin is made from purified human immunoglobulin G (IgG) antibodies obtained from pooled plasma collected from healthy donors.

Common trade names include Hizentra, Cuvitru, HyQvia, Gammanorm, Cutaquig, Xembify, and Subgam.

Several pharmaceutical companies manufacture SCIG products worldwide including CSL Behring, Takeda Pharmaceutical Company, and Grifols.

The generic name is Human Normal Immunoglobulin.

Common brand names include Hizentra, Cuvitru, HyQvia, Gammanorm, Cutaquig, Xembify, and Subgam.

Subcutaneous Immunoglobulin products are manufactured in several countries including the United States, Germany, Austria, and other regions by different plasma-derived pharmaceutical manufacturers.

It can be infused at home, gives steadier antibody levels, and causes fewer systemic reactions than monthly intravenous immunoglobulin.

Weekly or every two weeks, using a small pump. Facilitated SCIG with hyaluronidase (HyQvia) can be given every three to four weeks.

Most 20% products can be stored at room temperature (up to 25 °C) for the shelf life or a defined period; check the product labelling.

Related Products

Hyperimmune Globulins Intravenous (IV) or Subcutaneous (SC)

Strength:
100 mg/mL or 50 mg/mL

Form: Intravenous (IV) or Subcutaneous (SC) Solution

Reference Brands: Cytogam, RhoGAM (US)

View Details
Protein C Concentrate Powder

Strength:
5,000 IU/vial

Form: Lyophilized Powder

Reference Brands: Ceprotin(US)

View Details
Plasma Protein Fraction (PPF) 5% Solution

Strength:
50 mL, 250 mL, or 500 mL

Form: Solution for infusion

Reference Brands: Plasmanate (US)

View Details
Fresh Frozen Plasma (FFP) Powder for Reconstitution or Liquid

Strength:
available in 200-250 mL units

Form: liquid units or lyophilized (freeze-dried) powder

Reference Brands: -

View Details
Human Hepatitis B Immunoglobulin Injection 0.5ml

Strength:
200IU

Form: Injection

Reference Brands:

View Details
Human Normal Immunoglobulin 5% 10 % 50ML , 100ML

Strength:
2.5 GRAM , 5 GRAM , 10 GRAM , 16.5 GRAM

Form: Injection

Reference Brands: -

View Details
ANTI RH D Immunoglobulin

Strength:
250 IU, 500IU, 1500IU

Form: Injection

Reference Brands: RhoGAM (USA)

View Details
IVIG (Intravenous Immunoglobulin) Solution

Strength:
5% , 10%

Form: Intravenous infusion

Reference Brands: Gammagard, Privigen, Octagam, Kiovig, Flebogamma (US/EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us